# The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors

> **NCT06775080** · PHASE2 · RECRUITING · sponsor: **Huashan Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Gastrointestinal Tumors

## Interventions

- **DRUG:** propranolol (beta-blocker used treat high blood pressure)

## Key facts

- **NCT ID:** NCT06775080
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06775080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06775080, "The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06775080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*